Munich. (LMU)  Multiple sclerosis (MS) is the most common inflammatory disease of the central nervous system. There are many indications that MS is an autoimmune disease in which immune cells “accidentally” attack the brain and spinal cord. However, as with other autoimmune diseases, the actual triggers of the autoimmune reaction are still unknown. A new study by scientists from the SFB 128 demonstrated for the first time that gut bacteria of MS patients are able to trigger an MS-like disease in an animal model. More . . .

Mainz. Prof. Stefan Bittner joins fellow SFB 128 researcher Klaus Lehmann-Horn as the second 2017 recipient of research funding from the Hertie Foundation within the „MyLab” framework. Prof. Stefan Bittner will be funded by the program medMS My Lab to execute a new multi-year research project whose goal is to examine new mechanisms involved in neuronal degeneration in multiple sclerosis. More . . .

Munich. SFB CRC 128 researcher Dr. Klaus Lehmann-Horn, Department of Neurology, has acquired 396.000€ of funding as part of the framework „MyLab“, which is sponsored by the Hertie foundation. The duration of the project „Antigen-driven affinity maturation of B lymphocytes in meningeal ectopic lymphoid tissue in a model of Multiple Sclerosis“ will be 5 years, starting on January 1st.